603439 三力制药
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)5.37118.28321.60717.73015.127
总资产报酬率 ROA (%)2.6758.96612.35812.49611.434
投入资产回报率 ROIC (%)3.47012.54816.01214.49112.559

边际利润分析
销售毛利率 (%)68.65569.68973.31471.73970.499
营业利润率 (%)8.27815.21420.54018.77519.084
息税前利润/营业总收入 (%)9.43515.65420.38118.42518.859
净利润/营业总收入 (%)8.05813.05018.03515.97715.826

收益指标分析
经营活动净收益/利润总额(%)80.00599.43481.74597.10086.353
价值变动净收益/利润总额(%)-3.2240.60216.5144.92510.117
营业外收支净额/利润总额(%)7.216-0.376-0.541-1.343-1.439

偿债能力分析
流动比率 (X)1.4481.4561.7802.1363.051
速动比率 (X)1.1141.1971.5711.9572.805
资产负债率 (%)45.64450.04541.47031.83926.543
带息债务/全部投入资本 (%)32.26525.36424.91617.65115.625
股东权益/带息债务 (%)190.948267.350278.973455.599533.536
股东权益/负债合计 (%)113.89795.609121.403214.220276.585
利息保障倍数 (X)18.37531.490-413.682-182.271414.083

营运能力分析
应收账款周转天数 (天)166.098107.018100.05692.78492.425
存货周转天数 (天)267.685137.480112.95798.95588.422